Production (Stage)
Palisade Bio, Inc.
PALI
$0.6967
$0.01642.41%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 4.78% | -10.85% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -31.70% | -5.87% | |||
| Operating Income | 31.70% | 5.87% | |||
| Income Before Tax | 33.31% | 4.10% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 33.31% | 4.10% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 33.31% | 4.10% | |||
| EBIT | 31.70% | 5.87% | |||
| EBITDA | 31.73% | 5.85% | |||
| EPS Basic | 69.95% | 33.42% | |||
| Normalized Basic EPS | 69.95% | 33.42% | |||
| EPS Diluted | 69.95% | 33.42% | |||
| Normalized Diluted EPS | 69.95% | 33.42% | |||
| Average Basic Shares Outstanding | 121.91% | 44.03% | |||
| Average Diluted Shares Outstanding | 121.91% | 44.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||